Randomised, Placebo-Controlled, Double-Blind, Phase 2 Study of AG-013736 in Combination with Docetaxel Versus Docetaxel Alone in Patients with Metastatic Breast Cancer Preceeded by a Phase 1 Evaluation of the Combination.

  • Rea, Daniel (Principal Investigator)

Project Details

Short titleRandomised, Placebo-Controlled, Double-Blind, Phase 2 Study of AG-013736 in Combination with Docetaxel Versus Docetaxel Alone in Patients with Metastatic Breast Cancer Preceeded by a Phase 1 Evaluation of the Combination.
StatusFinished
Effective start/end date1/07/05 → 30/06/06

Funding

  • Queen Elizabeth Hospital Birmingham